Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The brains of individuals who have been addicted to opiate drugs show an increase in the number of hypocretin-expressing neurons — the same neurons that are lost in individuals with narcolepsy.
A study in flies shows that projections from some groups of glomerular neurons converge on certain types of lateral horn neurons to process combinations of odours that are salient for certain behaviours.
A set of 80 (mostly synaptic) proteins show hyperphosphorylation in sleep-deprived mice and genetically ‘sleepy’ mice, suggesting that increased phosphorylation of such proteins may be associated with sleep need.
Insights into the molecular and cellular mechanisms by which the APOE4 variant increases risk for Alzheimer disease are gained by comparing transcriptomes of neurons, astrocytes and microglia derived from isogenic APOE3- and APOE4-carrying iPSC cell lines.
In mice with experimental autoimmune encephalitis, dietary metabolites of tryptophan may modulate the activities of glia to influence neuroinflammation.
Opiate drugs and opioid peptides differ in their effects on intracellular signalling, in which following ligand–receptor binding and internalization, opioids continue to signal from endosomes, whereas opiates activate receptors located at the Golgi.
Although chronic pain is one of the most important medical problems facing society, there has been very limited progress in the development of novel therapies for this condition. Here, we discuss high-impact research priorities to reduce the number of people transitioning from acute to chronic intractable pain.